2009
DOI: 10.1248/bpb.32.1854
|View full text |Cite
|
Sign up to set email alerts
|

Sevoflurane Postconditioning Protects Chronically-Infarcted Rat Hearts against Ischemia-Reperfusion Injury by Activation of Pro-survival Kinases and Inhibition of Mitochondrial Permeability Transition Pore Opening upon Reperfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
32
0
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(37 citation statements)
references
References 53 publications
4
32
0
1
Order By: Relevance
“…Postconditioning with sevoflurane reduced myocardial apoptosis induced by I/R via multiple mechanisms, such as preventing activation of caspase 3/9 [18], and inhibiting the opening of mitochondrial permeability transition pore (mPTP) [9]. Clinical research uncovered that the molecular mechanisms of sevoflurane protection include its anti-inflammatory effects [19], which was consistent with our present finding.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Postconditioning with sevoflurane reduced myocardial apoptosis induced by I/R via multiple mechanisms, such as preventing activation of caspase 3/9 [18], and inhibiting the opening of mitochondrial permeability transition pore (mPTP) [9]. Clinical research uncovered that the molecular mechanisms of sevoflurane protection include its anti-inflammatory effects [19], which was consistent with our present finding.…”
Section: Discussionsupporting
confidence: 91%
“…Nevertheless, the combined effect is not tested in rat myocardial ischemia/reperfusion (I/R) model. Previous studies suggest that a variety of mechanisms may be responsible for the cardioprotection of SPC and RIPC against I/R injury, including the Reperfusion Injury Salvage Kinase pathway (RISK pathway) inhibition [8], preventing mitochondrial permeability transition pore (mPTP) from opening [9], decreasing intracellular reactive oxygen species (ROS) levels [10], and regulating the activation of autophagy or the process of autophagic flux [4,11]. However, the precise mechanisms remain unclear.…”
Section: Introductionmentioning
confidence: 99%
“…Several lncRNAs are dysregulated during acute myocardial infarction or heart failure, whereas others could control hypertrophy, mitochondrial function and cardiomyocyte apoptosis, and identified cardiovascular lncRNAs might play significant roles in cardiovascular diseases [36]. Previous studies have indicated that sevoflurane postconditioning could protect isolated mouse hearts against I/R injury [9,37]. A previous study showed that cAMP/PKA activation as a regulator could halt pathological cell recruitment, prevent destructive immune reactions, and promote hepatocyte survival, which might raise defensive thresholds to inflammatory responses [34].…”
Section: Discussionmentioning
confidence: 99%
“…For example, the JAK-STAT pathway plays an essential role in development of ischemic preconditioning-induced cardioprotection [190][191][192][193]. Protein kinase B/Akt [194][195][196] and protein kinase C (PKC) signaling [197][198][199][200][201][202][203][204][205] are implicated in protection against myocardial ischemic injury. Recent studies have proposed a comprehensive view of the reperfusion injury salvage kinase (RISK) pathway [206], which connects pro-survival (PI3K)-Akt and the p42 (ERK1/2) signaling, thus mediating the cardioprotection provided by ischemic and pharmacological preconditioning [207,208].…”
Section: Protein Phosphorylation and Cardiac Diseasesmentioning
confidence: 99%